Control of the transition to long-term nonprogressor in tristable HIV dynamics
暂无分享,去创建一个
A. Astolfi | A. Astolfi | H. Chang | H. Chang
[1] Martin A Nowak,et al. Mathematical models of HIV pathogenesis and treatment. , 2002, BioEssays : news and reviews in molecular, cellular and developmental biology.
[2] Robert F. Stengel,et al. Optimal enhancement of immune response , 2002, Bioinform..
[3] Hyungbo Shim,et al. A system theoretic study on a treatment of AIDS patient by achieving long-term non-progressor , 2009, Autom..
[4] H. Chang,et al. An Application of Gradual Reduction of Drug Dose to HIV Infection Model in Consideration of Drug Resistance and Drug Dose , 2006, 2006 SICE-ICASE International Joint Conference.
[5] Alan S. Perelson,et al. Mathematical Analysis of HIV-1 Dynamics in Vivo , 1999, SIAM Rev..
[6] R. D. de Boer,et al. Role of avidity and breadth of the CD4 T cell response in progression to AIDS , 2006, Proceedings of the Royal Society B: Biological Sciences.
[7] A. Astolfi,et al. Control of HIV Infection Dynamics by the Enhancement of the Immune System , 2008 .
[8] Hyungbo Shim,et al. Control of immune response of HIV infection model by gradual reduction of drug dose , 2004, 2004 43rd IEEE Conference on Decision and Control (CDC) (IEEE Cat. No.04CH37601).
[9] Hyeygjeon Chang,et al. Control of HIV Infection Dynamics , 2008, IEEE Control Systems.
[10] Alessandro Astolfi,et al. Control of HIV Infection Dynamics Control of HIV Infection Dynamics , 2008 .
[11] B. Walker,et al. Determinants of HIV-1 Mutational Escape From Cytotoxic T Lymphocytes , 2003, The Journal of experimental medicine.
[12] Alessandro Astolfi,et al. Activation of Immune Response in Disease Dynamics via Controlled Drug Scheduling , 2009, IEEE Transactions on Automation Science and Engineering.
[13] B. Adams,et al. HIV dynamics: Modeling, data analysis, and optimal treatment protocols , 2005 .
[14] D. Wodarz,et al. Helper-dependent vs. helper-independent CTL responses in HIV infection: implications for drug therapy and resistance. , 2001, Journal of theoretical biology.
[15] H. K. Altes,et al. The race between initial T–helper expansion and virus growth upon HIV infection influences polyclonality of the response and viral set–point , 2003, Proceedings of the Royal Society of London. Series B: Biological Sciences.
[16] Chung Choo Chung,et al. Optimal Scheduling of Drug Treatment for HIV Infection : Continuous Dose Control and Receding Horizon Control , 2003 .
[17] A. Perelson,et al. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection , 1995, Nature.
[18] Martin A Nowak,et al. Virus evolution within patients increases pathogenicity. , 2005, Journal of theoretical biology.
[19] G. Carcelain,et al. Boosting Immunity to HIV--Can the Virus Help? , 2000, Science.
[20] Leading to Long-Term Nonprogressor via Gradual Reduction of Drug Dose with Immune Dynamics Strongly Dependant on Target Cells , 2007, 2007 29th Annual International Conference of the IEEE Engineering in Medicine and Biology Society.
[21] Ryan Zurakowski,et al. A model predictive control based scheduling method for HIV therapy. , 2006, Journal of theoretical biology.
[22] J. Lisziewicz,et al. Control of HIV despite the discontinuation of antiretroviral therapy. , 1999, The New England journal of medicine.
[23] M. Nowak,et al. Specific therapy regimes could lead to long-term immunological control of HIV. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[24] Philip J. R. Goulder,et al. HIV and SIV CTL escape: implications for vaccine design , 2004, Nature Reviews Immunology.